Prehab for Pancreatic Cancer Surgery
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Massachusetts, Worcester
About this trial
The goal of this clinical study is to test whether a structured prehabilitation program can be successfully used by adults with pancreatic cancer who are receiving chemotherapy before planned surgery. Prehabilitation is a program designed to improve a person's physical fitness, nutrition, and symptom control before surgery.
The study's main hypothesis is that patients with pancreatic cancer can take part in and adhere to a multimodal prehabilitation program during chemotherapy, and that doing so may improve physical function, patient experience, and early recovery after surgery.
Eligibility criteria
Qualifiers
Age ≥ 18 years
Diagnosis of pancreatic ductal adenocarcinoma (PDAC)
Planned neoadjuvant chemotherapy prior to planned surgical resection
Medically stable and cleared to participate in physical activity/exercise programming
Disqualifiers
Age <18 years
Pregnant
Prisoner
Severe cognitive impairment that precludes informed consent or participation
Trial design
Treatments tested in this trial
- Multimodal Prehabilitation
Treatment groups
20 Participants
are divided into 1 treatment groupLocations
1UMass Memorial Medical Center01655, WoresterMassachusetts, United States
Sponsors and collaborators
University of Massachusetts, Worcester
Lead sponsor
Pancreatic Cancer Alliance
Collaborator
Source ClinicalTrials.gov